MetLife Investment Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.2K | Buy |
+26,359
| New | +$76.2K | ﹤0.01% | 2652 |
|
|
2025
Q1 | – | Sell |
-18,428
| Closed | -$71.3K | – | 2807 |
|
|
2024
Q4 | $71.3K | Sell |
18,428
-6,377
| -26% | -$24.7K | ﹤0.01% | 2706 |
|
|
2024
Q3 | $162K | Hold |
24,805
| – | – | ﹤0.01% | 2392 |
|
|
2024
Q2 | $180K | Buy |
24,805
+10,882
| +78% | +$78.9K | ﹤0.01% | 2318 |
|
|
2024
Q1 | $106K | Buy |
+13,923
| New | +$106K | ﹤0.01% | 2507 |
|
|
2018
Q4 | – | Sell |
-1,279
| Closed | -$179K | – | 2584 |
|
|
2018
Q3 | $179K | Buy |
+1,279
| New | +$179K | ﹤0.01% | 2145 |
|